tiprankstipranks
Enanta Pharmaceuticals Shareholders Affirm Management Direction
PremiumCompany AnnouncementsEnanta Pharmaceuticals Shareholders Affirm Management Direction
4M ago
Enanta price target lowered to $17 from $21 at Oppenheimer
PremiumThe Fly
Enanta price target lowered to $17 from $21 at Oppenheimer
5M ago
Enanta price target lowered to $26 from $40 at Baird
PremiumThe Fly
Enanta price target lowered to $26 from $40 at Baird
5M ago
Enanta price target lowered to $28 from $30 at H.C. Wainwright
PremiumThe FlyEnanta price target lowered to $28 from $30 at H.C. Wainwright
8M ago
Enanta price target lowered to $23 from $42 at JMP Securities
PremiumThe Fly
Enanta price target lowered to $23 from $42 at JMP Securities
8M ago
Enanta sees FY24 R&D expense $100M-$120M
PremiumThe Fly
Enanta sees FY24 R&D expense $100M-$120M
8M ago
S&P announces changes to S&P 400, 600 indices at open on 9/18
PremiumThe FlyS&P announces changes to S&P 400, 600 indices at open on 9/18
11M ago
Enanta downgraded to Underweight from Neutral at JPMorgan
PremiumThe Fly
Enanta downgraded to Underweight from Neutral at JPMorgan
11M ago
Enanta price target lowered to $42 from $65 at JMP Securities
PremiumThe Fly
Enanta price target lowered to $42 from $65 at JMP Securities
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100